Filing Details
- Accession Number:
- 0001209191-16-088041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-04 19:19:58
- Reporting Period:
- 2015-12-30
- Filing Date:
- 2016-01-04
- Accepted Time:
- 2016-01-04 19:19:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879407 | Arrowhead Research Corp | ARWR | Services-Commercial Physical & Biological Research (8731) | 460408024 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1486672 | Allen Kenneth Myszkowski | 225 S. Lake Avenue Suite 1050 Pasadena CA 91101 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-12-30 | 13,153 | $6.13 | 108,347 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-12-30 | 23,347 | $6.13 | 85,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-01-01 | 50,000 | $0.00 | 135,000 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Acquisiton | 2016-01-01 | 40,000 | $0.00 | 40,000 | $6.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
362,000 | 2026-01-01 | No | 4 | A | Direct |
Footnotes
- Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments on the anniversary date of the grant.
- Option vests and becomes exercisable over a four year period from date of grant.